Literature DB >> 188991

Studies on cyclic AMP in different compartments of cerebrospinal fluid.

D Tsang, S Lal, T L Sourkes, R M Ford, A Aronoff.   

Abstract

Adenosine 3', 5'-monophosphate (cAMP) was measured in the CSF of 42 patients undergoing radiological investigation, neurosurgical procedures, or investigation of hepatic coma. The concentration of cAMP was significantly higher in ventricular CSF than in lumbar CSF. Premedication with pentobarbitone plus promethazine increased cAMP in lumbar CSF. There was no difference in cAMP concentration in lumbar CSF obtained before or after injection of air or after the administration of diazepam during lumbar pneumoencephalography. Lumbar CSF cAMP concentration was significantly increased in patients in hepatic coma. The concentration of cAMP in the lateral ventricle was not affected by general anaesthesia or by the presence of a complete block of the aqueduct of Sylvius. There was no decrease in lumbar CSF cAMP in patients with a complete stenosis of the aqueduct of Sylvius, partial blocks of CSF flow at the cervical level, or a complete block at the lower thoracic level. The concentration of cisternal CSF cAMP was similar to that of lumbar CSF. These results suggest that (1) there is a ventriculolumbar gradient in the concentration of cAMP but of insufficient magnitude to be detected by mixing of lumbar and ventricular CSF during pneumoencephalography, (2) lumbar CSF cAMP concentration is not dependent on brain as a source of this nucleotide; the source of this nucleotide may be largely derived from the spinal cord, (3) premedication may affect the concentration of cAMP in lumbar CSF cAMP, (4) the formation of cAMP is unimpaired in hepatic coma.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 188991      PMCID: PMC492563          DOI: 10.1136/jnnp.39.12.1186

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Proceedings: Cyclic adenosine-3', 5'-monophosphate in cerebrospinal fluid.

Authors:  M J Dascombe; A S Milton
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  Cyclic AMP in cerebrospinal fluid: accumulaiton following probenecid and biogenic amines.

Authors:  J B Sebens; J Korf
Journal:  Exp Neurol       Date:  1975-02       Impact factor: 5.330

3.  Cyclic adenosine-3',5-monophosphate concentration and enzyme activities of cerebrospinal fluid in meningitis of children.

Authors:  E R Heikkinen; S Similä; V V Myllylä; E Hokkanen; H Vapaatalo
Journal:  Z Kinderheilkd       Date:  1975-11-13

4.  Cerebrospinal fluid concentration and urinary excretion of cyclic adenosine-3', 5'-monophosphate in various diseases of children.

Authors:  V V Myllylä; E R Heikkinen; S Similä; E Hokkanen; H Vapaatalo
Journal:  Z Kinderheilkd       Date:  1975

5.  Evidence for disordered cyclic amp metabolism in patients with cerebral infarction.

Authors:  K M Welch; J S Meyer; A N Chee
Journal:  Eur Neurol       Date:  1975       Impact factor: 1.710

6.  Cyclic amp concentration and enzyme activities of cerebrospinal fluid in patients with epilepsy or central nervous system damage.

Authors:  V V Myllylä; E R Heikkinen; H Vapaatalo; E Hokkanen
Journal:  Eur Neurol       Date:  1975       Impact factor: 1.710

7.  Cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid, lactic acid, and pH before and after probenecid in hepatic coma.

Authors:  S Lal; A Aronoff; E Garelis; T L Sourkes; S N Young; C E de la Vega
Journal:  Clin Neurol Neurosurg       Date:  1975-12       Impact factor: 1.876

8.  Effects of probenecid and exercise on cerebrospinal-fluid cyclic A.M.P. in affective illness.

Authors:  H Cramer; F K Goodwin; R M Post; W E Bunney
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

9.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

10.  Cyclic A.M.P. in affective disorders.

Authors:  G A Robison; A J Coppen; P C Whybrow; A J Prange
Journal:  Lancet       Date:  1970-11-14       Impact factor: 79.321

View more
  3 in total

1.  The effect of L-dopa and propranolol on human CSF cyclic nucleotides.

Authors:  R H Belmaker; R P Ebstein; J Biederman; R Stern; M Berman; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

2.  Hypothalamic-pituitary dopaminergic function in hepatic failure in man.

Authors:  S Lal; M Oravec; A Aronoff; M E Kiely; H Guyda; S Solomon; N P Nair
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

3.  CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Patrick Oeckl; Petra Steinacker; Stefan Lehnert; Sarah Jesse; Hans A Kretzschmar; Albert C Ludolph; Markus Otto; Boris Ferger
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.